SECOND SIGHT MEDICAL PRODUCT (EYES)
US81362J3086 - Common Stock
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 56.38M | 69.59M | 3.18M | 11.33M | 4.47M | |||
| Receivables | N/A | N/A | N/A | 455.00K | 504.00K | |||
| Inventories | N/A | N/A | 0.00 | 1.03M | 3.25M | |||
| Other Current Assets | 1.01M | 914.00K | 1.09M | 299.00K | 1.40M | |||
| Total Current Assets | 57.39M | 70.51M | 4.27M | 13.11M | 9.62M | |||
| Non-Current Assets | ||||||||
| PPE Net | 243.00K | 345.00K | 174.00K | 3.46M | 1.02M | |||
| Investments And Advances | 8.02M | 27.00K | 17.00K | 25.00K | 37.00K | |||
| Total Non-Current Assets | 8.26M | 372.00K | 191.00K | 3.49M | 1.06M | |||
| TOTAL ASSETS | 65.65M | 70.88M | 4.46M | 16.60M | 10.68M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 2.20M | N/A | N/A | |||
| Accrued Expenses | 1.29M | 1.94M | 2.11M | 5.53M | 6.13M | |||
| Accounts Payable | 966.00K | 519.00K | 486.00K | 1.09M | 1.30M | |||
| Other Current Liabilities | 335.00K | N/A | 335.00K | 335.00K | 167.00K | |||
| Total Current Liabilities | 2.59M | 2.46M | 5.13M | 6.96M | 7.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 52.00K | 0.00 | 2.37M | N/A | |||
| Total Non-Current Liabilities | 0.00 | 52.00K | 0.00 | 2.37M | 0.00 | |||
| TOTAL LIABILITIES | 2.59M | 2.51M | 5.13M | 9.32M | 7.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -333.87M | -328.58M | -319.66M | -304.78M | -269.47M | |||
| Additional Paid In Capital | 49.41M | 49.39M | 49.31M | 48.61M | 44.11M | |||
| Common Shares | 347.94M | 347.94M | 270.13M | 264.01M | 229.02M | |||
| Other Shareholders' Equity | -424.00K | -379.00K | -448.00K | -562.00K | -575.00K | |||
| Shares Outstanding | 13.14M | 13.14M | 7.74M | 5.21M | 3.18M | |||
| Tangible Book Value per Share | 4.80 | 5.20 | -0.09 | 1.40 | 0.97 | |||
| Total Shareholders' Equity | 63.06M | 68.36M | -672.00K | 7.28M | 3.08M | |||
| TOTAL LIABILITIES AND EQUITY | 65.65M | 70.88M | 4.46M | 16.60M | 10.68M | |||
| Statistics | ||||||||
| Current Ratio | 22.15 | 28.64 | 0.83 | 1.88 | 1.27 | |||
| Return On Assets (ROA) | -13.82% | -12.59% | -333.63% | -202.37% | -328.53% | |||
| Return On Equity (ROE) | -14.39% | -13.05% | N/A | -461.75% | -1137.94% | |||
All data in USD